SCHEMBL2376027

SCHEMBL2376027

COCCN(C)C(=O)[C@H](Cc1ccccc1)N(Cc1ccc(-c2ccccn2)cc1)C(=O)/C=C/c1ccc(OC)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.40
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
HTR5A P47898 3/20 0.37
ALDH1A1 P00352 2/20 0.36
ABCB1 P08183 2/20 0.35
PPARG P37231 1/20 0.35
MLNR O43193 1/20 0.35
NR1I2 O75469 1/20 0.35
SLCO2B1 O94956 1/20 0.35
ABCB11 O95342 1/20 0.35
UGT1A1 P22309 1/20 0.35
CCKAR P32238 1/20 0.35
OPRK1 P41145 1/20 0.35
GHSR Q92847 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
KDM4E B2RXH2 1/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2376030 1.00 TRPM8 (0.40) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2376033 1.00 TRPM8 (0.40) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2364092 0.93 HTR5A (0.42) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2364095 0.93 HTR5A (0.42) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2364093 0.93 HTR5A (0.42) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2374315 0.92 HTR5A (0.39) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2374311 0.92 HTR5A (0.39) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2374309 0.92 HTR5A (0.39) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2375069 0.91 TRPM8 (0.38) TRPM8KMT2AMAPK1HTR5AALDH1A1
SCHEMBL2375079 0.91 TRPM8 (0.38) TRPM8KMT2AMAPK1HTR5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110224210-A1 NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-15 US claimed
US-20110224210-A1 NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224210-A1 NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS CTSA, BECN1, HDAC6 TRPM8 2184/4885KMT2A 515/4885MAPK1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.